SOPHiA GENETICS (SOPH) Change in Cash (2020 - 2025)

SOPHiA GENETICS has disclosed Change in Cash across 6 years of filings, most recently posting -$12.0 million for Q4 2025.

• Change in Cash for Q4 2025 came in at -$12.0 million, up 8.31% year-over-year; the trailing twelve-month figure through Dec 2025 was -$14.4 million (up 63.5% YoY), and the FY2025 annual result was -$14.4 million, up 63.5% from the prior year.
• Change in Cash came in at -$12.0 million for Q4 2025 at SOPHiA GENETICS, up from -$13.4 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $168.8 million in Q3 2021 to a low of -$20.5 million in Q3 2022.
• The 5-year median for Change in Cash is -$12.5 million (2021), against an average of -$182950.0.
• Across the five-year window, Change in Cash plunged 1242.96% in 2023 and jumped 1610.29% in 2025, its largest moves.
• SOPHiA GENETICS's Change in Cash stood at -$17.2 million in 2021, then jumped by 107.16% to $1.2 million in 2022, then slumped by 1242.96% to -$14.0 million in 2023, then gained by 6.64% to -$13.1 million in 2024, then gained by 8.31% to -$12.0 million in 2025.
• The last three Change in Cash figures came in at -$12.0 million (Q4 2025), -$13.4 million (Q3 2025), and $23.8 million (Q2 2025), per Business Quant data.